Results 331 to 340 of about 23,125,138 (369)

A function for interleukin 2 in Foxp3-expressing regulatory T cells

Nature Immunology, 2005
J. Fontenot, J. P. Rasmussen, M. Gavin, A. Rudensky   +3 more
semanticscholar   +1 more source

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

New England Journal of Medicine, 1985
S. Rosenberg, M. Lotze, L. Muul, S. Leitman, A. E. Chang, S. Ettinghausen, Y. Matory, J. Skibber, E. Shiloni, J. Vetto, C. Seipp, Colleen G. Simpson, C. Reichert   +12 more
semanticscholar   +1 more source

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Nature Medicine, 2016
Jing He, Xia Zhang, Yunbo Wei, Xiaolin Sun, Yaping Chen, Jun Deng, Yuebo Jin, Y. Gan, Xin Hu, R. Jia, Chuanhui Xu, Zhaohua Hou, Y. A. Leong, Lei Zhu, Jinhong Feng, Y. An, Yuan Jia, Chun Li, Xu Liu, H. Ye, L. Ren, Ru Li, H. Yao, Yu-hui Li, Shi Chen, Xuewu Zhang, Yin Su, Jianping Guo, N. Shen, E. Morand, Di Yu, Zhanguo Li   +31 more
semanticscholar   +1 more source

Interleukin-2

Cancer Investigation, 1989
openaire   +3 more sources

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

New England Journal of Medicine, 1988
S. Rosenberg, B. S. Packard, P. Aebersold, D. Solomon, S. Topalian, S. T. Toy, P. Simon, M. Lotze, James C. Yang, C. Seipp, Colleen G. Simpson, C. Carter, S. Bock, D. Schwartzentruber, John P. Wei, D. White   +15 more
semanticscholar   +1 more source

Interleukin-2: inception, impact, and implications.

Science, 1988
Kendall A. Smith
semanticscholar   +1 more source

Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response

The Prostate, 2016
R. Junghans, Q. Ma, R. Rathore, E. Gomes, A. Bais, Agnes Lo, M. Abedi, R. Davies, Howard J. Cabral, A. Al-Homsi, Stephen I. Cohen   +10 more
semanticscholar   +1 more source

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.

Journal of Clinical Oncology, 1999
M. Atkins, M. Lotze, J. Dutcher, R. Fisher, G. Weiss, K. Margolin, J. Abrams, M. Sznol, D. Parkinson, M. Hawkins, C. Paradise, L. Kunkel, S. Rosenberg   +12 more
semanticscholar   +1 more source

Interleukin 2

Reactions, 1988
E, Bijvank, J, van Loo
  +5 more sources

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

Nature reviews. Immunology, 2015
D. Klatzmann, A. Abbas
semanticscholar   +1 more source